Literature DB >> 11595299

The immunology of HIV-infected long-term non-progressors--a current view.

M Paroli1, A Propato, D Accapezzato, V Francavilla, E Schiaffella, V Barnaba.   

Abstract

Long-term non-progressors (LTNP) are human immunodeficiency virus (HIV)-infected individuals characterized by the absence of disease, low viral loads and stable or even increasing CD4(+) T cell counts for prolonged periods of time. In these subjects, an HIV-specific immune response which is either stronger or directed against a wider array of viral epitopes than that seen in progressors, can be often detected. Here, we summarize the characteristics of HIV-specific CD4(+) and CD8(+) T cell responses in LTNP, and discuss how a highly effective T cell-mediated immune response against HIV might contribute to the establishment of this particular condition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11595299     DOI: 10.1016/s0165-2478(01)00274-7

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  5 in total

1.  Higher NK cell IFN-γ production is associated with delayed HIV disease progression in LTNPs.

Authors:  Yongjun Jiang; Fangyuan Zhou; Yao Tian; Zining Zhang; Rongmei Kuang; Jing Liu; Xiaoxu Han; Qinghai Hu; Junjie Xu; Hong Shang
Journal:  J Clin Immunol       Date:  2013-09-03       Impact factor: 8.317

2.  Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression.

Authors:  Claudia Pastori; Barbara Weiser; Claudia Barassi; Caterina Uberti-Foppa; Silvia Ghezzi; Renato Longhi; Giliola Calori; Harold Burger; Kimdar Kemal; Guido Poli; Adriano Lazzarin; Lucia Lopalco
Journal:  Blood       Date:  2006-03-07       Impact factor: 22.113

3.  Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors.

Authors:  Sumathi Sankaran; Moraima Guadalupe; Elizabeth Reay; Michael D George; Jason Flamm; Thomas Prindiville; Satya Dandekar
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-24       Impact factor: 11.205

Review 4.  Current progress in the development of a prophylactic vaccine for HIV-1.

Authors:  Lena J Gamble; Qiana L Matthews
Journal:  Drug Des Devel Ther       Date:  2010-12-22       Impact factor: 4.162

5.  Non-polarized cytokine profile of a long-term non-progressor HIV infected patient.

Authors:  Ana Flávia Pina; Vanessa Terezinha Gubert de Matos; Camila Mareti Bonin; Márcia Maria Ferrairo Janini Dal Fabbro; Inês Aparecida Tozetti
Journal:  Braz J Infect Dis       Date:  2018-02-21       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.